| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Apr 9, 2019 | CPIX Cumberland Pharmaceuticals Inc | Kazimi A J59 | Chairman And CEO | Buy | 1,526 | $6.13 | $9,350.73 | - | |
| Apr 9, 2019 | CPIX Cumberland Pharmaceuticals Inc | Krogulski Kenneth55 | Director | Buy | 1,596 | $6.12 | $9,770.83 | +0.1% | |
| Apr 9, 2019 | CPIX Cumberland Pharmaceuticals Inc | Jacobs Joey A | Director | Buy | 3,166 | $6.11 | $19,336.13 | +0.6% | |
| Apr 9, 2019 | CPIX Cumberland Pharmaceuticals Inc | Galante Joseph C47 | Director | Buy | 1,526 | $6.13 | $9,350.73 | +2.8% | |
| Apr 8, 2019 | MRK Merck & Co., Inc. | Merck & Co., Inc. | 10% Owner | Buy | 4,121,683 | $16.00 | $65,946,928.00 | +46.7% | |
| Apr 5, 2019 | LLY Eli Lilly & Co | Shah Aarti S. | SVP &CIO | Sell | 1,800 | $125.85 | $226,530.00 | -8.9% | |
| Apr 5, 2019 | TLRY Tilray Brands, Inc. | Pastorius Edward Wood Jr | Chief Revenue Officer | Sell | 3,443 | $61.04 | $210,160.72 | -19.0% | |
| Apr 5, 2019 | NVS Novartis AG | Novartis Bioventures Ltd | 10% Owner | Sell | 130,594 | $0.99 | $129,244.90 | -0.8% | |
| Apr 4, 2019 | BCRX Biocryst Pharmaceuticals Inc | Staab Thomas R II | Senior Vice President And CFO | Sell | 7,500 | $8.81 | $66,075.00 | -5.4% | |
| Apr 3, 2019 | ESPR Esperion Therapeutics, Inc. | Bartram Richard | Chief Financial Officer | Sell | 8,000 | $42.88 | $343,045.00 | -25.2% | |
| Apr 2, 2019 | TLRY Tilray Brands, Inc. | Pastorius Edward Wood Jr | Chief Revenue Officer | Sell | 46,557 | $63.38 | $2,950,947.42 | -38.3% | |
| Apr 2, 2019 | TLRY Tilray Brands, Inc. | Kennedy Brendan87 | President And CEO | Sell | 106,109 | $63.44 | $6,732,056.06 | -12.7% | |
| Apr 2, 2019 | NVS Novartis AG | Novartis Bioventures Ltd | 10% Owner | Sell | 231,763 | $0.94 | $218,685.93 | -1.4% | |
| Apr 1, 2019 | AMRN Amarin Corp Plc\uk | Ketchum Steven B | Chief Scientific Officer | Sell | 9,542 | $20.06 | $191,391.99 | -1.3% | |
| Apr 1, 2019 | HROW Harrow, Inc. | Kammer Robert J | Director | Sell | 10,000 | $4.77 | $47,700.00 | -1.2% | |
| Apr 1, 2019 | ALKS Alkermes Plc. | Mitchell Paul J | Director | Sell | 1,000 | $36.64 | $36,640.00 | -100% | |
| Apr 1, 2019 | ZTS Zoetis Inc. | Lagano Roxanne70 | Executive Vice President | Sell | 2,000 | $101.89 | $203,780.00 | -6.5% | |
| Apr 1, 2019 | EGRX Eagle Pharmaceuticals, Inc. | Tarriff Scott | CEO | Sell | 24,975 | $50.15 | $1,252,496.25 | -1.6% | |
| Apr 1, 2019 | LNTH Lantheus Holdings, Inc. | Schaffer Derace L | Director | Sell | 10,000 | $24.41 | $244,094.00 | -17.5% | |
| Apr 1, 2019 | AMRN Amarin Corp Plc\uk | Kennedy Joseph T | General Counsel | Sell | 54,172 | $20.05 | $1,086,121.58 | -46.0% | |
| Apr 1, 2019 | NVS Novartis AG | Novartis Bioventures Ltd | 10% Owner | Sell | 127,150 | $1.86 | $236,258.00 | -3.0% | |
| Apr 1, 2019 | BUDZ Weed, Inc. | Breen Nicole M | Secretary And Treasurer | Sell | 62,349 | $1.03 | $64,036.92 | - | |
| Mar 29, 2019 | ESPR Esperion Therapeutics, Inc. | Mayleben Timothy M | President &CEO | Buy | 5,000 | $40.00 | $200,000.00 | +8.9% | |
| Mar 28, 2019 | NVS Novartis AG | Novartis Bioventures Ltd | 10% Owner | Sell | 317,346 | $0.99 | $313,286.03 | -1.9% | |
| Mar 27, 2019 | RMTI Rockwell Medical, Inc. | Richmond David S. | 10% Owner, See Footnotes 1 And 2 | Buy | 5,869 | $5.59 | $32,788.34 | +1.3% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.